Skip to main content

Table 1 Patient characteristics, monitoring and functional outcome

From: Intraoperative continuous cerebral microcirculation measurement in patients with aneurysmal subarachnoid hemorrhage: preliminary data on the early administration of magnesium sulfate

Patient No.

Age range

Comorbidity

SAB grade (WFNS)

Aneurysm location

Side

Probe placement

SEP monitoring

Pathological SEP?

Vasospasm/related neurological deficite?

mRS at discharge

mRS at 12 months

1

3

AH

V

AcoA

L

temporal

Posterior tibial nerve

yes

no

5

4

2

2

AH

II

ACA

R

temporal

n.a.

n.a.

yes/no

1

1

3

2

AH

III

AcoA

L

frontal

Posterior tibial nerve

yes

yes/no

2

1

4

1

none

II

ACA

R

temporal

Posterior tibial nerve

no

yes/no

0

0

5

3

none

IV

AcoA

R

frontal

Posterior tibial nerve

yes

no

2

1

6

2

AH

II

MCA

R

temporal

Median nerve

no

no

2

2

7

1

none

IV

MCA

L

temporal

Median nerve

yes

no

3

3

8

3

AH

II

AcoA

L

temporal

Posterior tibial nerve

no

no

1

0

9

3

AH

V

AcoA

L

frontal

Posterior tibial nerve

yes

yes/yes

6

6

10

2

AH

III

MCA

R

temporal

Median nerve

yes

yes/no

4

4

11

3

AH

IV

MCA

R

temporal

Median nerve

no

yes/no

1

0

12

4

AH, CAD, HI

V

MCA

L

temporal

n.a.

n.a.

no

6

6

13

2

AH

II

MCA

R

frontal

Median nerve

yes

yes/no

1

1

14

1

AH

III

MCA

L

temporal

Median nerve

yes

yes/yes

3

3

  1. Age range (years) 1 = 40–49, 2 = 50–59, 3 = 60–69, 4 = 80–85. AcoA anterior communicating artery, ACA anterior cerebral artery, MCA middle cerebral artery, AH arterial hypertension, CAD coronary artery disease, HI heart insufficiency, mRS modified Rankin Scale, WFNS World Federation of Neurosurgical Societies